Koninklijke Philips (NYSE:PHG) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Koninklijke Philips (NYSE:PHG) have received an average rating of “Moderate Buy” from the five research firms that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company.

PHG has been the topic of several analyst reports. UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. StockNews.com downgraded shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Finally, BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th.

Koninklijke Philips Price Performance

Shares of Koninklijke Philips stock opened at $27.16 on Monday. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $25.52 billion, a price-to-earnings ratio of -32.33, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77. Koninklijke Philips has a twelve month low of $19.10 and a twelve month high of $32.91. The company has a 50-day simple moving average of $26.44 and a two-hundred day simple moving average of $28.01.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The business had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. Analysts forecast that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently announced an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be paid a dividend of $0.886 per share. This represents a yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s payout ratio is -89.29%.

Institutional Trading of Koninklijke Philips

Hedge funds have recently added to or reduced their stakes in the stock. Colonial Trust Co SC lifted its stake in shares of Koninklijke Philips by 724.0% in the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company’s stock valued at $36,000 after acquiring an additional 1,238 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Koninklijke Philips during the third quarter valued at about $54,000. Farther Finance Advisors LLC grew its holdings in shares of Koninklijke Philips by 37.1% during the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after purchasing an additional 582 shares during the last quarter. Whipplewood Advisors LLC acquired a new position in Koninklijke Philips in the 4th quarter valued at approximately $55,000. Finally, Millstone Evans Group LLC acquired a new stake in Koninklijke Philips in the fourth quarter valued at $60,000. Institutional investors and hedge funds own 13.67% of the company’s stock.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.